Brian Low Financial Group LLC Takes Position in SPDR S&P Biotech ETF $XBI

Brian Low Financial Group LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 6,664 shares of the exchange traded fund’s stock, valued at approximately $668,000.

Other large investors have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. raised its position in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares during the last quarter. Meitav Investment House Ltd. increased its stake in shares of SPDR S&P Biotech ETF by 2,199.6% during the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock worth $33,229,000 after purchasing an additional 383,040 shares in the last quarter. Strs Ohio acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $27,801,000. JPMorgan Chase & Co. raised its position in shares of SPDR S&P Biotech ETF by 2.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock worth $882,218,000 after purchasing an additional 268,399 shares during the last quarter. Finally, Marshall Wace LLP lifted its stake in SPDR S&P Biotech ETF by 102.3% in the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after buying an additional 179,029 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $124.98 on Friday. The stock has a market cap of $7.59 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $126.50. The business’s fifty day moving average price is $117.08 and its two-hundred day moving average price is $100.07.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.